clinical trial · NCT01622543
Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
Canadian Cancer Trials Group·phase2·completed·n = 109
Colorectal CancerFolfox plus Bevacizumab and reolysinFolfox plus Bevacizumab
brief summary
The purpose of this study is to find out if giving reolysin in combination with FOLFOX6/ bevacizumab can offer better results than standard therapy with FOLFOX6/ bevacizumab.
started
Oct 26, 2012
primary completion
Jan 18, 2017
completion
Sep 12, 2018
last updated
Aug 23, 2023
detailed description
Researchers doing this study also want to evaluate the side effects of reolysin when given together with FOLFOX6/ bevacizumab.
official title
A Randomized Phase II Study of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Patients With Metastatic Colorectal Cancer.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol